French recommendations for the management of Takayasu’s arteritis
David Saadoun, A. Bura-Rivière, C. Comarmond, M. Lambert, Alban Redheuil, Tristan Mirault, Collaborators, Paul Achouh, Florence A. Aeschlimann, Jean-Marc Alsac, Laurent Arnaud, Y. Benhamou, Boris Bienvenu, Eric Bodiguel, Olivia Boyer, L. Chiche, J. Constans, Raphaël Darbon, Sandrine Guibaudet, Philippe Lamarche, Séverin Ferrand, Olivier Espitia, S. Franchi, Julien Gaudric, P. Giordana, É. Hachulla, Pierre‐Yves Hatron, A. Hot, Isabelle Koné‐Paut, Hélène Maillard, A. Mékinian, Pierre Quartier, T. Quéméneur, Mickael Soussan, Marc Sapoval, J. Schmidt, Gilles Soulat
Abstract
The aim of this National Diagnostic and Care Protocol (PNDS) is to explain to the professionals involved the current optimal diagnosis and therapeutic management and care approach for a patient with Takayasu's arteritis. Its purpose is to optimize and harmonize the management and follow-up of this rare disease throughout the country. It also identifies pharmaceutical specialties used in an indication not provided for in the Marketing Authorization, as well as the specialties, products or services necessary for the care of patients but not usually paid for or reimbursed.